Science Diet MetabolicMouse strain differences in metabolic fluxes and function of ex vivo working heartspossibly another form of stress challenges deserves furtherinvestigations. ACKNOWLEDGMENTSWe thank Dr. Nathalie Thorin- Trescases for helpful comments, as well as. Ovid Da Silva, France Th. Vaillant: Centre de Recherche Cardio- thoracique,INSERM U1. L’Institut de RYthmologie et de Mod. Metabolic Research Center offers a holistic approach to weight loss. Our plans are easy to follow and you'll lose weight quickly. NDM/Z-endoxifen . Researchers at the Mayo Clinic Cancer Center are developing a new drug to help women with estrogen receptor positive breast cancer who are unable to derive benefit. Start studying Hepatic Drug metabolism and Drug Interactions. Learn vocabulary, terms, and more with flashcards, games, and other study tools. Lauzier: L’Institut du Thorax, INSERM, UMR- 1. CNRS, UMR- 6. 29. Universit. Des Rosiers and Grant No. Thisfunding source had no role in our study. DISCLOSURESNo con. Aasum E, Lathrop DA, Henden T, Sundset R, Larsen TS. The role ofglycolysis in myocardial calcium control. J Mol Cell Cardiol 3. Science Diet Metabolic FelineTamoxifen and metabolites plasma concentrations and metabolic ratios according to CYP3A4 and. Endoxifen; EM-F. Metabolic Actions of Estrogen Receptor Beta (ER. DOI: 10.1371/journal.pgen.1000108. Drug metabolism is a clinically important. A metabolomic approach to lipidopathies. Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, Cleland JG,Maggioni A, Fonarow GC, Abel ED, Campia U, Gheorghiade M. Targeting myocardial substrate metabolism in heart failure: potential fornew therapies. Eur J Heart Fail 1. Barnabei MS, Palpant NJ, Metzger JM. Physiol Genomics 4. A: 1. 03–1. 13, 2. Barrick CJ, Rojas M, Schoonhoven R, Smyth SS, Threadgill DW. Cardiac response to pressure overload in 1. S1/Sv. Im. J and C5. BL/6. Jmice: temporal- and background- dependent development of concentric leftventricular hypertrophy. Am J Physiol Heart Circ Physiol 2. H2. 11. 9 –H2. 13. Bendall JK, Heymes C, Wright TJ, Wheatcroft S, Grieve DJ, Shah. AM, Cave AC. Strain- dependent variation in vascular responses to nitricoxide in the isolated murine heart. J Mol Cell Cardiol 3. Berglund ED, Li CY, Poffenberger G, Ayala JE, Fueger PT, Willis SE,Jewell MM, Powers AC, Wasserman DH. Glucose metabolism in vivoin four commonly used inbred mouse strains. Diabetes 5. 7: 1. Berthonneche C, Peter B, Schupfer F, Hayoz P, Kutalik Z, Abriel H,Pedrazzini T, Beckmann JS, Bergmann S, Maurer F. Cardiovascularresponse to beta- adrenergic blockade or activation in 2. PLo. S One 4: e. 66. Boardman NT, Larsen TS, Severson DL, Essop MF, Aasum E. Chronic and acute exposure of mouse hearts to fatty acids increasesoxygen cost of excitation- contraction coupling. Am J Physiol Heart Circ. Physiol 3. 00: H1. H1. 63. 6, 2. 01. Broberg CS, Pantely GA, Barber BJ, Mack GK, Lee K, Thigpen T,Davis LE, Sahn D, Hohimer AR. Validation of the myocardial perfor- mance index by echocardiography in mice: a noninvasive measure of leftventricular function. J Am Soc Echocardiogr 1. Busseuil D, Shi Y, Mecteau M, Brand G, Gillis MA, Thorin E, Asselin. C, Romeo P, Leung TK, Latour JG, Des Rosiers C, Bouly M,Rheaume E, Tardif JC. Heart rate reduction by ivabradine reducesdiastolic dysfunction and cardiac . Cardiology 1. 17: 2. Cook SA, Clerk A, Sugden PH. Are transgenic mice the =alkahest=tounderstanding myocardial hypertrophy and failure? J Mol Cell Cardiol 4. Dansky HM, Charlton SA, Sikes JL, Heath SC, Simantov R, Levin. LF, Shu P, Moore KJ, Breslow JL, Smith JD. Genetic backgrounddetermines the extent of atherosclerosis in Apo. E- de. Arterio- scler Thromb Vasc Biol 1. Dunn ME, Manfredi TG, Cosmas AC, Vetter FJ, King JN, Rodgers. RL. Mechanical function, glycolysis, and ultrastructure of perfused work- ing mouse hearts following thoracic aortic constriction. Cardiovasc Pathol. Dyck JR, Lopaschuk GD. AMPK alterations in cardiac physiology andpathology: enemy or ally? J Physiol 5. 74: 9. Esworthy RS, Smith DD, Chu FF. A strong impact of genetic back- ground on gut micro. Garcia- Menendez L, Karamanlidis G, Kolwicz S, Tian R. Substrainspeci. Am JPhysiol Heart Circ Physiol 3. H3. 97–H4. 02, 2. Gelinas R, Labarthe F, Bouchard B, Mc Duff J, Charron G, Young. ME, Des Rosiers C. Alterations in carbohydrate metabolism and itsregulation in PPAR. Am J Physiol Heart Circ Physiol. H1. 57. 1–H1. 58. Gelinas R, Thompson- Legault J, Bouchard B, Daneault C, Mansour. A, Gillis MA, Charron G, Gavino V, Labarthe F, Des Rosiers C. Prolonged QT interval and lipid alterations beyond . Am J Physiol. Heart Circ Physiol 3. H8. 13–H8. 23, 2. Glatz JF, Luiken JJ, Bonen A. Membrane fatty acid transporters asregulators of lipid metabolism: implications for metabolic disease. Physiol. Rev 9. 0: 3. Hafstad AD, Khalid AM, Hagve M, Lund T, Larsen TS, Severson DL,Clarke K, Berge RK, Aasum E. Cardiac peroxisome proliferator- acti- vated receptor- alpha activation causes increased fatty acid oxidation,reducing ef. Cardiovasc Res. 83: 5. Haluzik M, Colombo C, Gavrilova O, Chua S, Wolf N, Chen M,Stannard B, Dietz KR, Le Roith D, Reitman ML. Genetic background(C5. BL/6. J versus FVB/N) strongly in. Endocrinology 1. 45: 3. Hoit BD, Kiatchoosakun S, Restivo J, Kirkpatrick D, Olszens K, Shao. H, Pao YH, Nadeau JH. Naturally occurring variation in cardiovasculartraits among inbred mouse strains. Genomics 7. 9: 6. Hue L, Beauloye C, Marsin AS, Bertrand L, Horman S, Rider MH. Insulin and ischemia stimulate glycolysis by acting on the same targetsthrough different and opposing signaling pathways. J Mol Cell Cardiol 3. Kassiotis C, Rajabi M, Taegtmeyer H. Metabolic reserve of the heart: the forgotten link between contraction and coronary . Prog Cardio- vasc Dis 5. Khairallah M, Khairallah R, Young ME, Dyck JR, Petrof BJ, Des. Rosiers C. Metabolic and signaling alterations in dystrophin- de. J Mol Cell Cardiol 4. Khairallah M, Labarthe F, Bouchard B, Danialou G, Petrof BJ, Des. Rosiers C. Am J Physiol Heart Circ Physiol 2. H1. 46. 1–H1. 47. Khairallah RJ, Khairallah M, Gelinas R, Bouchard B, Young ME,Allen BG, Lopaschuk GD, Deschepper CF, Des Rosiers C. Cyclic GMPsignaling in cardiomyocytes modulates fatty acid traf. J Mol Cell Cardiol 4. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolismin. Am J Physiol Heart Circ. Physiol 2. 78: H1. H1. 35. 1, 2. 00. Lauzier B, Merlen C, Vaillant F, Mc. Duff J, Bouchard B, Beguin PC,Dolinsky VW, Foisy S, Villeneuve LR, Labarthe F, Dyck JR, Allen. BG, Charron G, Des Rosiers C. Post- translational modi. J Mol Cell Cardiol 5. H8. 6 MOUSE STRAINS AND CARDIAC METABOLISMAJP- Heart Circ Physiol.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
August 2017
Categories |